arrow
P

Pengpeng Qu

Tianjin Central Hospital of Gynecology Obstetrics
H指数:21
被引数:1,533

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cadonilimab plus chemotherapy with or without bevacizumab as first-line treatment for advanced cervical cancer: subgroup analyses from the COMPASSION-16 phase 3 trial

卡度尼利单抗联合化疗,联合或不联合贝伐珠单抗作为晚期宫颈癌的一线治疗:COMPASSION-16 III期试验的亚组分析

2026-03-140
OAAI
Pegylated liposomal doxorubicin plus carboplatin versus paclitaxel plus carboplatin as first-line therapy for epithelial ovarian cancer (CGCS-04): a multicenter, randomized clinical trial

聚乙二醇化脂质体多柔比星联合卡铂与紫杉醇联合卡铂作为上皮性卵巢癌的一线治疗(CGCS-04):一项多中心、随机临床试验

2026-02-160
OA
Exploratory biomarker analysis in the phase III L-MOCA study of olaparib maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer
2024-05-164
OAAI
Senaparib as first-line maintenance therapy in advanced ovarian cancer: a randomized phase 3 trial
2024-05-154
PRE